Categories: Pharmacy

GSK provides update on LATITUDE-TIMI 60 (losmapimod cardiovascular study)

The FINANCIAL — GSK on October 27 announced that, as per the stepwise trial design of its losmapimod phase III study, LATITUDE-TIMI 60, an interim review of data from part A of the study (an initial cohort of 3,503 patients) did not indicate efficacy against the primary endpoint and did not support investment in the larger part B of the study as currently designed. 

In the available data from this interim assessment, an efficacy signal in a sub-population of patients (n=866) classified with ST elevation myocardial infarction (STEMI) has been identified.  Although not statistically significant, due to the relatively small number of events (n=59), reductions between 30% and 50% in the pre-specified endpoints of cardiovascular death, hospitalisation for heart failure, and the composite of the two were observed, according to GSK.

GSK will assess these findings over the next few months to evaluate all options for future development. 




Published by

Recent Posts

Gartner Finance Survey Shows 55% of Functions Aiming for a Touchless Close by 2025

A February 2022 survey of 155 finance executives revealed that 55% of respondents are aiming…

5 hours ago

Gartner Survey Reveals Marketing Analytics are Only Influencing 53% of Decisions

Marketing analytics are responsible for influencing just over half (53%) of marketing decisions, according to…

5 hours ago

Home values in U.S. decline for second month as competition eases

In addition to affordability challenges, recent volatility in mortgage rates is making it difficult for…

5 hours ago

Gartner Identifies Key Emerging Technologies Expanding Immersive Experiences, Accelerating AI Automation and Optimizing Technologist Delivery

The 25 emerging technologies to watch on the Gartner, Inc. Hype Cycle for Emerging Technologies,…

6 hours ago

World is More Concerned About Climate Change, Decline in Worry About the Coronavirus

Four in ten (40%) globally say inflation is one of the biggest issues affecting their…

6 hours ago

The BMW M Hybrid V8 has arrived in North America

Los Angeles. The BMW M Hybrid V8 has arrived in North America and was presented…

6 hours ago